Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference


EXTON, Pa., March 11 -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt Hotel in New York on Wednesday, March 26, 2008.

Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning at approximately 11:35 a.m. (ET). The presentation materials will be available on the company's website (http://www.kenseynash.com/) beginning at 11:35 a.m. (ET) on Wednesday, March 26, 2008.

About Kensey Nash Corporation Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

Source: Kensey Nash

CONTACT: Joseph W. Kaufmann, President and Chief Executive Officer of Kensey Nash, +1-484-713-2100

Web site: http://www.kenseynash.com/

All Topics